Some sections appear to be highly speculative (e.g. "treatment of Parkinson's disease and Alzheimer's disease") and likely the section could be shortened to a single sentence indicating a potential use for ghrelin/GHSR agonists given the role of dopamine in these disorders and their management. Here, GHRL is linked to Parkinson disease.